WEDNESDAY, Aug. 28, 2024 -- Semaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points...
Vous n'êtes pas connecté
By Gabriella Peralta and PA Staff The GHA is awaiting further guidance after UK health officials have given the green light for a weight-loss jab to be used to prevent heart attacks and strokes in overweight people. Semaglutide, sold under the brand name Wegovy, has already been approved for weight management in people with obesity...
WEDNESDAY, Aug. 28, 2024 -- Semaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points...
Semaglutide – contained in Ozempic and Wegovy – has ‘far-reaching benefits’, with people dying at lower rate from all causes
MONDAY, Aug. 26, 2024 -- Increases in eligibility for semaglutide are discussed in a research letter published online Aug. 27 in the Annals of...
TUESDAY, Sept. 3, 2024 -- Treatment with semaglutide does not increase the risk for developing symptoms of depression or suicidal ideation/behavior...
FRIDAY, Aug.30, 2024 -- New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more...
Pharmaceuticals such as Ozempic, Wegovy and Mounjaro aren't risk-free. The FDA says it has received reports of people overdosing on compounded...
Pharmaceuticals such as Ozempic, Wegovy and Mounjaro aren't risk-free. The FDA says it has received reports of people overdosing on compounded...
A recent study conducted by the University of Freiburg has raised concerns about the use of aspirin, particularly in individuals who are at risk of...
A recent study conducted by the University of Freiburg has raised concerns about the use of aspirin, particularly in individuals who are at risk of...
Reducing the risk of heart disease and keeping a healthy weight are made possible by physical activity. Adolescents should exercise moderately to...